TOFACITINIB
NDC 76333-111, TOFACITINIB, tablet, film coated, extended release, from Orient Pharma Co., Ltd. Yunlin Plant.
- Product NDC
- 76333-111
- Status
- Listed
- Labeler
- Orient Pharma Co., Ltd. Yunlin Plant
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219830
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76333-111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE11 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76333-111-15 | 76333011115 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (76333-111-15) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5617a652-a78e-74b1-e063-6394a90a31c7
Use it
Look up 76333-111 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76333-111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76333-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.